Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?
- Gengsheng Chen
- , Nicole S. McKay
- , Brian A. Gordon
- , Jingxia Liu
- , Nelly Joseph-Mathurin
- , Suzanne E. Schindler
- , Jason Hassenstab
- , Andrew J. Aschenbrenner
- , Qing Wang
- , Stephanie A. Schultz
- , Yi Su
- , Pamela J. LaMontagne
- , Sarah J. Keefe
- , Parinaz Massoumzadeh
- , Carlos Cruchaga
- , Chengjie Xiong
- , John C. Morris
- , Tammie L.S. Benzinger
- Neuroimaging Labs Research Center
- Institute of Clinical and Translational Sciences (ICTS)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Biomedical Informatics and Data Science
- DBBS - Neurosciences
- Hope Center for Neurological Disorders
- Siteman Cancer Center
- DBBS - Human and Statistical Genetics
- DBBS - Molecular Genetics and Genomics
- McDonnell Genome Institute (MGI)
- Bursky Center for Human Immunology and Immunotherapy
- NeuroGenomics and Informatics Center
- COVID-19 Researchers
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- Center for Biostatistics and Data Science (CBDS)
- Department of Neurology
- Section of Neuroradiology
- Division of Basic Science Research
- Section of Aging & Dementia
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Scopus
citations